View Post

G-CSF Cuts Febrile Neutropenia Rates in Early Breast Cancer

In Clinical Studies News by Barbara Jacoby

By: Liam Davenport From: medscape.com Women with early-stage breast cancer had a significantly lower rate of febrile neutropenia when given granulocyte-colony stimulating factors (G-CSF) alongside their chemotherapy rather than the antibiotic ciprofloxacin, indicate new data from a randomized trial. The research was presented at the 2020 annual meeting of the American Society of Clinical Oncology, held virtually because of the …